Test Price
2,700 AEDโ Home Collection Available
Genetic Mapping for Oncology & Cancer Risk Assessment Test in UAE | 2700 AED | DHA Licensed
Executive Summary & Core Metrics
Test Overview & Methodology
The Genetic Mapping for Oncology & Cancer Risk Assessment Test is a comprehensive SNP microarray assay that screens germline DNA for hundreds of cancer-susceptibility genes, empowering oncologists and researchers with actionable risk stratification. This genome-wide analysis provides polygenic risk scores and copy number variant detection far beyond the scope of single-gene sequencing panels.
| Feature | Our Test (Genetic Mapping Oncology) | Closest Alternative (Single-Gene Sequencing) |
|---|---|---|
| Precision / Method | SNP Microarray + Chromosomal Microarray (genome-wide) | Sanger or NGS panels (limited gene set) |
| Turnaround Time | 8 weeks (comprehensive analysis) | 2-4 weeks (targeted) |
| Clinical Value | Polygenic risk scores + CNV detection | Known pathogenic variants only |
Physician Insight & Safety Protocols
โAs a Consultant Medical Genetics specialist, I recognize the power of comprehensive genetic mapping to unveil hidden cancer predispositions. While this test provides advanced risk information, it must be interpreted alongside family history and clinical findingsโnever in isolation. I advise all patients to discuss results with a qualified genetic counselor or oncologist before making any medical decisions.โ
โ Lina Osama Zaki Quteineh (DHA Registration ID: 9294403)
Advisory Notice on Result Interpretation
โ ๏ธ Important Clinical Advisory
Genetic risk profiles do not replace current treatment plans. Never discontinue prescribed medication without consulting your physician. Risk stratification results from this test should always be validated through confirmatory diagnostic procedures before any clinical action is taken.
Safety Exclusion Criteria & Emergency Red Flags
- Age below 18 years: This test is not validated for minors; guardian consent and pediatric genetic counseling are required.
- Inability to provide 3 mL whole blood or refusal of consent form (Form 26).
- Active hematologic cancer or bone marrow transplant within 3 months (may yield non-germline results).
ER Red Flags: If you experience severe anxiety, suicidal ideation, or acute distress after receiving genetic risk information, please contact emergency services immediately or call our support line for urgent counseling referral.
Patient FAQ & Clinical Guidance
1. What is the accuracy of this genetic mapping test for detecting breast cancer risk?
Our SNP microarray delivers a validated 99.9% analytical sensitivity for detecting BRCA1/2 and other high-penetrance alleles, far surpassing traditional single-gene tests in polygenic assessment. The test also evaluates moderate-penetrance genes and polygenic risk scores for a more complete risk picture.
2. How long does it take to receive results for the oncology genetic mapping test?
The final report is issued within 8 weeks from sample receipt. This extended turnaround time reflects the complexity of microarray analysis and the interpretation of hundreds of genetic loci according to accredited clinical protocols.
3. Is home blood collection safe and certified in the UAE for genetic testing?
Yes, our VIP Mobile Phlebotomy service is licensed under DHA facility number 1143, uses ISO-certified cold-chain transport, and follows strict infection control protocols, ensuring sample integrity from your home to our laboratory. Service is available daily from 8 AM to 11 PM.
4. Can this test detect all types of cancer predisposition?
This genome-wide SNP microarray evaluates hundreds of known cancer-susceptibility genes and chromosomal regions. While it is one of the most comprehensive genetic screening tools available, no single test can detect all possible cancer predispositions. Results should be interpreted by a qualified genetic specialist.
UAE Regulatory & Data Privacy Adherence
๐ก๏ธ Data Protection & Compliance Framework
This test is conducted in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is encrypted, access-controlled, and processed within secure UAE-based infrastructure.
Clinical safety and patient consent procedures adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability, ensuring that every test is accompanied by informed consent and pre- and post-test genetic counseling.
ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139). DHA Facility License Number: 1143.
Clinical & Logistical Metadata
| Test Name | Genetic Mapping for Oncology & Cancer Risk Assessment |
| Price (AED) | 2,700 AED |
| Turnaround Time | 8 weeks from sample receipt |
| Sample Type / Matrix | Peripheral whole blood (3 mL) in EDTA tube. VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM. |
| Methodology Used | SNP Microarray + Chromosomal Microarray (genome-wide analysis) |
| ICD-10-CM Code | Z15.09, Z13.89 |
| LOINC Code | 81247-9 |
| DHA Facility License & Laboratory Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians